Formulation-dependent differences in paclitaxel distribution to anatomical sites relevant to chemotherapy-induced peripheral neuropathy
In the case of similar unbound paclitaxel concentration in the plasma of patients and assumed species-independent extent of paclitaxel transport across the barriers, nab- and micellar-PTX formulations can lead to higher paclitaxel exposure at CIPN-sites in comparison to CreEL-PTX.
Authors
- Irena Loryan (ORCID: https://orcid.org/0000-0002-1557-4416)
- Yang Hu (ORCID: https://orcid.org/0000-0002-8702-6654)
- Margareta Hammarlund‐Udenaes (ORCID: https://orcid.org/0000-0002-9181-1321)
- Milda Girdenyté (ORCID: https://orcid.org/0000-0002-3701-3847)
- Aghavni Ginosyan
Institutions
- Uppsala University (SE)
- Vilnius University (LT)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2024-11-06
- DOI
- https://doi.org/10.3389/fphar.2024.1486686
- Citations
- 7
- Primary Topic
- Cancer Treatment and Pharmacology
- Type
- article
- Field-Weighted Citation Impact
- 1.98
Funders
- Vetenskapsrådet
- Innovative Medicines Initiative